[177Lu]Lu-NeoB

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for [177Lu]Lu-NeoB, covering 2025-08-21 to 2026-02-03. Get the full timeline:

Most recent: Clinical Trial Update: Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma [Phase 1]